top of page

【ARCFE News】 ARCFE RECEIVED 7 MORE I-765 APPROVALS FOR EB-5 CONCURRENT FILING

Congratulations to our investors and their dependents for receiving I-765 approvals in just 3 months of filing!

As of date, ARCFE have received a total of 13 I-765 approvals for EB-5 concurrent filing under the EB-5 Reform and Integrity Act of 2022 – all within 3 months of filing their petitions concurrently. Investors will receive their EAD card within 30 days from the notice date. They will be able to legally work in the U.S. beginning from the “start date” on their EAD card while waiting for their I-526E petition to be processed.

The EB-5 Reform and Integrity Act of 2022 (“RIA”) offers great benefits to investors and their families, including concurrent filing. Concurrent filing allows investors who are already in the U.S. under a different visa category to file their I-526E petition at the same time with form I-485 to adjust their status without leaving the U.S. This also gives investors and their families immediate freedom to live, study and work in the U.S. while waiting for their Green Cards to be approved.

When investor chooses to do concurrent filing, they will need to file these four forms at the same time:

  1. Form I-526E (“Immigrant Petition by Regional Center Investor”)

  2. Form I-485 (“Application to Register Permanent Residence or Adjust Status”)

  3. Form I-131 (“Application for Travel Document”)

  4. Form I-765 (“Application for Employment Authorization”) – EAD Card

According to the New Cycle Time Goals USCIS announced back in March of this year, they aim to process the I-765 and I-131 petitions within 3 months, in which the I-765 will be adjudicated first. USCIS processes these two petitions separately to reduce I-765 processing times. 

Source: https://www.uscis.gov/newsroom/news-releases/uscis-announces-new-actions-to-reduce-backlogs-expand-premium-processing-and-provide-relief-to-work

New York Office

28-07 Jackson Ave, 8th FL, LIC, NY 11101

212-889-5333

info@arcfe.com

0 views
bottom of page